Nestmedic S.A.

What Nestmedic S.A. does

Nestmedic S.A. is a Poland-based telemedicine company focused on remote fetal well-being monitoring via mobile cardiotocography (CTG). Its product system combines CE-certified Class IIa medical hardware (the original Pregnabit device for home use from 32 weeks of pregnancy and the advanced Pregnabit Pro with GSM 4G / Wi-Fi real-time data transmission) with the Pregnabit Cloud SaaS platform that receives, analyses, and prioritises CTG recordings. A separate cooperating entity, Medyczne Centrum Telemonitoringu (MCT), operates the Medical Telemonitoring Center where qualified personnel provide 24/7 review of incoming examinations, adding a managed-services layer on top of the hardware and software stack.

The company monetises through three streams: sale or rental of mobile CTG hardware to pregnant women and medical facilities (including direct e-commerce via pregnabit.com/sklep/), recurring SaaS licences for the Pregnabit Cloud platform charged to hospitals and channel partners, and managed telemonitoring services delivered through MCT. Underlying technology is anchored by proprietary algorithms for fetal heart rate analysis at 4 Hz with per-sample reliability scoring, maternal-fetal rhythm coincidence detection, and automated abnormality detection that drives the Description Center triage workflow. All products are MDR-compliant under Regulation 2017/745 with TÜV Nord Poland as Notified Body, and no medical incidents have been reported.

Nestmedic pursues a hybrid B2B2C and direct-to-consumer go-to-market model. Exclusive multi-year distribution agreements with Synektik (Poland, Czech Republic, Slovakia) and ScanMed A/S (Norway and Denmark, through end-2027) handle enterprise sales into hospitals via public procurement tenders, while the e-commerce storefront and direct outreach to midwives support consumer-side rentals and purchases. The company is publicly listed on the Warsaw Stock Exchange's NewConnect market under ticker NEST, with Deutsche Balaton Aktiengesellschaft holding 34.16% and 5HT Fundacja Rodzinna holding 19.83% as the two largest shareholders.

Name

Nestmedic S.A.

Legal name

Nestmedic Spółka Akcyjna

Website

https://nestmedic.com

Company type

Public

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

Nestmedic S.A. is a Polish telemedicine company that develops CE-certified mobile cardiotocography (CTG) devices and the Pregnabit Cloud SaaS platform for remote fetal monitoring, serving pregnant women, hospitals, and medical professionals across Poland and selected European markets.

Ownership category

akta.pro rank

Product category

Telemedicine Fetal Monitoring Devices

NAICS

Electromedical and Electrotherapeutic Apparatus Manufacturing (334510), Surgical and Medical Instrument Manufacturing (339112)

SIC

Surgical & Medical Instruments & Apparatus (3841), Services-Prepackaged Software (7372)

akta.pro primary industry

Maternal & Neonatal Remote Monitoring Platforms (HLACAFAC)

akta.pro secondary industries

Maternal & High-Risk Pregnancy Remote Monitoring (BP, glucose, fetal/uterine monitoring) (HLALAFAG), Pregnancy & Prenatal Care Telehealth (OB tele-visits, prenatal monitoring) (HLALAHAC), Maternal, Fetal & Neonatal Monitoring (CTG, Infant Wearables) (HLAHACAF)

Keywords

• Mobile CTG devices
• Telemedicine fetal monitoring
• Remote cardiotocography
• Obstetric telemedicine platforms
• Medical telemonitoring services

Headquarters

HQ city

Wroclaw

HQ country

Poland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Mobile CTG Device Sales and Rental: Nestmedic manufactures and sells or rents mobile CTG devices (Pregnabit, Pregnabit Pro) to pregnant women and medical facilities. Devices can be purchased or rented through the online store at pregnabit.com/sklep/.
2. Pregnabit Cloud SaaS Platform Licences: Software-as-a-Service platform licence fees charged to medical professionals and institutions for access to the Pregnabit Cloud telemedicine platform, which processes CTG examination data and provides analysis tools. Also licensed to distribution partners such as ScanMed A/S.
3. Medical Telemonitoring Center Services: Continuous 24/7 monitoring service at the Medical Telemonitoring Center (MCT), where qualified medical personnel analyze incoming CTG recordings and provide preliminary medical assessment, generating recurring service revenue.

Go-to-market motion2 records

Distribution channels4 records

Marketing channels4 records

Core offering

Nestmedic S.A. manufactures and sells mobile cardiotocography (CTG) devices (Pregnabit and Pregnabit Pro) that enable pregnant women to perform remote fetal well-being monitoring at home. The hardware is paired with the Pregnabit Cloud SaaS telemedicine platform, which receives, stores and analyses CTG recordings and provides professional interfaces for doctors and midwives. The offering is completed by a 24/7 Medical Telemonitoring Center staffed by qualified medical personnel who analyse incoming recordings and provide preliminary assessment.

Product overview

Nestmedic S.A. offers a unified telemedicine system for fetal well-being monitoring, consisting of hardware devices and a cloud platform. The portfolio includes the original Pregnabit mobile CTG device for home use, the advanced Pregnabit Pro device with enhanced features and real-time data transmission capabilities, the Pregnabit Cloud SaaS platform for receiving and analyzing CTG data with professional interfaces for healthcare providers, and the PregnaView patient-facing module. Together, these products enable remote CTG examinations (teleCTG), professional analysis by medical staff at the Medical Telemonitoring Center, and convenient home-based pregnancy monitoring for patients in their third trimester.

Differentiator

Problem solved

Functional benefit

Brands

• Pregnabit: Mobile CTG device for remote fetal well-being monitoring, enabling pregnant women to perform cardiotocography examinations at home from 32nd week of pregnancy.
• Pregnabit Pro
• Pregnabit Cloud

Products and services

• Pregnabit Original mobile cardiotocography (CTG) device for home use, enabling pregnant women with single pregnancy from 32 weeks to perform fetal monitoring examinations anywhere and anytime without hospital visits.
• Pregnabit Pro Advanced mobile CTG device operating in a telediagnostic model for remote monitoring of fetal well-being. Measures fetal heart rate (FHR), uterine contraction activity (TOCO), fetal movements and maternal heart rate (MHR), and transmits CTG examination data in near real time via GSM 4G or Wi-Fi to the Pregnabit Cloud platform. Designed for medical professionals and pregnant patients in the third trimester.
• Pregnabit Cloud SaaS telemedicine platform that receives and analyses CTG examination data from telemedical devices. Provides interfaces for doctors and midwives to manage medical data, view examination results, and includes a Description Center module for remote supervision and prioritisation of patients using telemedical CTG devices.
• PregnaView Patient-facing component of the Pregnabit system, classified as a separate Class IIa medical device, providing functionality for viewing CTG examination results and related health information for pregnant patients.
• Medical Telemonitoring Center (MCT) Service Continuous 24/7 monitoring service in which qualified medical personnel at the Medical Telemonitoring Center analyse incoming CTG recordings and provide preliminary medical assessment, supported by algorithms that prioritise examinations based on detected abnormalities.

Quantifiable outcome

• No medical incidents ever reported for any Nestmedic medical device (Pregnabit, PregnaView, Pregnabit Cloud)
• +2 more outcomes

Named customers3 records

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• ScanMed A/S DenmarkcoreChannel Partner/ Reseller/ Distributor · 6 November 2023Nestmedic signed a distribution agreement with ScanMed A/S Denmark granting the right to distribute and resell Pregnabit Pro devices and licence to use the Pregnabit Cloud Platform in Denmark. The agreement runs until 31 December 2027. ScanMed A/S is the major medical equipment supplier in the Nordic region, supplying most hospitals primarily through public tenders with contracts ranging from 2 to 6 years.
• ScanMed A/S NorwaycoreChannel Partner/ Reseller/ Distributor · 31 October 2023Nestmedic signed a distribution agreement with ScanMed A/S Norway granting the right to distribute and resell Pregnabit Pro devices and licence to use the Pregnabit Cloud Platform in Norway. The agreement runs until 31 December 2027, with sales plans for 2024 and 2025 to be defined by end of March 2024. First orders were expected in Q4 2023. ScanMed Group was founded in 1982 by Bjørn Johnsen and generates EUR 25 million in annual turnover, supplying the majority of hospitals in the Nordic market.
• Synektik S.A.coreChannel Partner/ Reseller/ Distributor · 3 August 2023Nestmedic signed a strategic 3-year distribution agreement (with renewal option) with Synektik making it the exclusive distributor of Pregnabit Pro devices and Pregnabit Cloud telemedicine platform in Poland, Czech Republic (from 1 September 2023), and Slovakia. Synektik is a medical technology integrator focused on oncology, cardiology, and neurology, distributing solutions such as the Da Vinci robotic surgical system. Nestmedic views this partnership as key to regional commercial expansion.
• Medyczne Centrum Telemonitoringu Sp. z o.o. (MCT)coreStrategic or Co-development PartnerMCT is a cooperating entity that serves as the Medical Telemonitoring Center within the Pregnabit system, where qualified medical personnel continuously analyze incoming CTG recordings. MCT is registered at the same address as Nestmedic (ul. Pasymska 20, Warsaw). MCT is a separate legal entity and independent data controller.
• EDOKTOR24.PL Sp. z o.o.coreStrategic or Co-development PartnerEDOKTOR24.PL is an independent administrator of personal data of Users, including Patients, in connection with the provision of services within the Pregnabit Platform. Located at ul. Lwowska 15/6, Warsaw. Nestmedic has a data sharing arrangement with EDOKTOR24.PL for patient data processing.
• Capital One Advisers Sp. z o.o.minorImplementation/ SI/ Consulting PartnerCapital One Advisers Sp. z o.o. serves as Nestmedic's authorized financial advisor, located at Al. Ujazdowskie 41, Warsaw. Provides advisory services related to the company's capital market activities.
• Dom Maklerski BOŚ SAminorImplementation/ SI/ Consulting PartnerDom Maklerski BOŚ SA serves as Nestmedic's market maker on the Warsaw Stock Exchange, facilitating trading of the company's shares on the NewConnect market.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Broad incumbents

• Philips (Maternal & Fetal Monitoring): Philips is a global medical device incumbent with a broad portfolio of maternal-fetal monitoring solutions, including the Avalon FM series for CTG and remote monitoring. It competes with Nestmedic in hospital tenders, but operates at vastly larger scale and as part of a multi-modality franchise.
• GE Healthcare (Maternal-Infant Care): GE Healthcare offers a comprehensive line of fetal/maternal monitoring products (Corometrics, Novii) that compete with Nestmedic in hospital settings. As a broad incumbent, it bundles fetal monitoring with broader diagnostic imaging and patient monitoring portfolios.
• Hologic: Hologic is a women's health-focused medical device and diagnostics company with products spanning obstetrics, prenatal screening, and connected diagnostics. It is comparable to Nestmedic as a broader women's-health incumbent, with a much wider portfolio and deeper hospital channel reach.

Direct peers

• MindChild Medical: MindChild Medical developed the Meridian fetal monitoring system for non-invasive fetal heart rate monitoring. It is a direct competitor to Nestmedic in the mobile/ambulatory CTG device category targeting maternal-fetal monitoring in clinical and remote settings.
• PeriGen: PeriGen provides AI-powered perinatal decision-support software that analyses CTG data and integrates with hospital EMRs. It is comparable to the Pregnabit Cloud Description Center module, applying algorithmic analysis to fetal monitoring data, though PeriGen focuses on in-hospital rather than home-based monitoring.
• OB-Tools: OB-Tools is a UK-based specialist in obstetric CTG training, interpretation software, and decision-support tools for clinicians. Comparable to Nestmedic as a focused provider of CTG-related digital health tooling for maternity care professionals.
• Babyscripts: Babyscripts is a US-based virtual maternity care platform that combines remote patient monitoring devices, a mobile app, and clinician dashboards for prenatal and postpartum care. It is a direct competitor to Nestmedic in the remote maternal monitoring category with a similar device-plus-software-plus-services model.
• Mahmee: Mahmee is a maternal-infant health platform offering telehealth, in-home nursing, and care coordination for pregnancy and postpartum. It is a direct competitor to Nestmedic in the digital maternal-health telehealth space, with overlapping focus on remote monitoring and clinical oversight.

Emerging players

• HeraBEAT: HeraBEAT has developed a consumer-grade fetal heart rate monitor paired with a smartphone app for at-home pregnancy monitoring. It overlaps with Nestmedic's direct-to-consumer use case at pregnabit.com, but lacks the full teleCTG clinical analysis stack and MDR-certified hardware.
• K2 Medical Systems: K2 Medical Systems provides CTG interpretation training, e-learning, and decision-support software used by obstetricians and midwives. It overlaps with Nestmedic in digital tooling for CTG analysis, although K2 is more focused on education and standalone interpretation software.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nestmedic S.A.